Blood samples from brain tumor patients could unlock future discoveries

NCT ID NCT05480644

Recruiting now Knowledge-focused Sponsor: Duke University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is creating a collection of blood samples from 300 adults with primary or metastatic brain tumors. Researchers will analyze immune cells in the blood to better understand these tumors. The goal is to provide a resource for future studies, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this repository could help researchers discover new biomarkers or immune patterns that may guide future treatments for brain tumors.
What could go wrong: This is an observational study that does not test any treatment, so it will not directly benefit participants. The findings may not lead to immediate clinical applications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRAIN METASTASES, ADULT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain cancer metastatic malignant neoplasm in the brain primary brain neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRAIN METASTASES, ADULT BRAIN TUMOR, PRIMARY

Contacts and locations

Locations

Duke Cancer Center
RECRUITING

Durham, North Carolina, 27710, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.